Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures
- PMID: 16867995
- DOI: 10.1074/jbc.M603721200
Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures
Abstract
Transforming growth factor beta (TGF-beta) modulates a number of cellular phenotypes as divergent as growth stimulation and growth inhibition. Although the Smad pathway is critical for many of these responses, recent evidence indicates that Smad-independent pathways may also have a critical role. One such protein previously shown to regulate TGF-beta action independent of the Smad proteins is the c-Abl nonreceptor tyrosine kinase. In the current study we determined that TGF-beta receptor signaling activates c-Abl kinase activity in a subset of fibroblast but not epithelial cultures. This cell type-specific response occurs in a membrane-proximal locale independent of receptor internalization and upstream of dynamin action. Although c-Abl activation by TGF-beta is independent of Smad2 or Smad3, it is prevented by inhibitors of phosphatidylinositol 3-kinase or PAK2. Thus, c-Abl represents a target downstream of phosphatidylinositol 3-kinase-activated PAK2, which differentiates TGF-beta signaling in fibroblasts and epithelial cell lines and integrates serine/threonine receptor kinases with tyrosine kinase pathways.
Similar articles
-
Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.Cancer Res. 2007 Apr 15;67(8):3673-82. doi: 10.1158/0008-5472.CAN-06-3211. Cancer Res. 2007. PMID: 17440079
-
Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.FASEB J. 2005 Jan;19(1):1-11. doi: 10.1096/fj.04-2370com. FASEB J. 2005. PMID: 15629889
-
Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3.Mol Cell Biol. 2003 Dec;23(23):8878-89. doi: 10.1128/MCB.23.23.8878-8889.2003. Mol Cell Biol. 2003. PMID: 14612425 Free PMC article.
-
[Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].Yakugaku Zasshi. 2021;141(11):1229-1234. doi: 10.1248/yakushi.21-00143. Yakugaku Zasshi. 2021. PMID: 34719542 Review. Japanese.
-
Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.Cell Signal. 2013 Oct;25(10):2017-24. doi: 10.1016/j.cellsig.2013.06.001. Epub 2013 Jun 11. Cell Signal. 2013. PMID: 23770288 Review.
Cited by
-
Activation of abl family kinases in solid tumors.Genes Cancer. 2012 May;3(5-6):414-25. doi: 10.1177/1947601912458586. Genes Cancer. 2012. PMID: 23226579 Free PMC article.
-
p21-Activated kinase 2 (PAK2) inhibits TGF-β signaling in Madin-Darby canine kidney (MDCK) epithelial cells by interfering with the receptor-Smad interaction.J Biol Chem. 2012 Apr 20;287(17):13705-12. doi: 10.1074/jbc.M112.346221. Epub 2012 Mar 5. J Biol Chem. 2012. PMID: 22393057 Free PMC article.
-
The Role of TGF-β Receptors in Fibrosis.Open Rheumatol J. 2012;6:156-62. doi: 10.2174/1874312901206010156. Epub 2012 Jun 15. Open Rheumatol J. 2012. PMID: 22802914 Free PMC article.
-
Serine-204 in the linker region of Smad3 mediates the collagen-I response to TGF-β in a cell phenotype-specific manner.Exp Cell Res. 2013 Nov 15;319(19):2928-37. doi: 10.1016/j.yexcr.2013.07.013. Epub 2013 Sep 27. Exp Cell Res. 2013. PMID: 24080014 Free PMC article.
-
Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis.Arthritis Rheum. 2008 Aug;58(8):2219-24. doi: 10.1002/art.23634. Arthritis Rheum. 2008. PMID: 18668575 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous